A coagulation panel is a group of blood tests that measure how quickly and how effectively your blood forms a clot to stop bleeding, and how well it later dissolves that clot. It maps the clotting cascade — the chain of proteins, called clotting factors, that turn liquid blood solid — and reads it from both directions: too slow points to a bleeding risk, too active points to a clotting risk.
What the coagulation panel measures
Clotting is a relay. When a vessel is injured, clotting factors activate one after another until they convert soluble fibrinogen into a mesh of fibrin that seals the wound; other proteins then keep the clot from spreading and later break it down. The lab reads this system through two overlapping pathways. The prothrombin time and INR test one arm of the cascade, the aPTT tests the other, and both share a final common stretch. Fibrinogen is the raw material for the clot, and D-dimer is a fragment left behind when a clot is broken down. Because no single test sees the whole cascade, the tests are read together — the pattern of which values are normal and which are prolonged is what localizes the problem.
Which tests are included
- Prothrombin Time (PT) — times one arm of the cascade; sensitive to warfarin, liver disease and low vitamin K.
- INR — the PT standardized across labs, and the number used to dose and monitor warfarin.
- aPTT — times the other arm; used to monitor heparin and to screen for hemophilia.
- Fibrinogen — the protein that becomes the clot; low when it is used up quickly, high with inflammation.
- D-Dimer — a clot-breakdown fragment; a sensitive test that helps rule out a deep-vein thrombosis or pulmonary embolism.
- Thrombin Time (TT) — checks the final fibrinogen-to-fibrin step; flags heparin or a fibrinogen problem.
- Antithrombin III — a natural brake on clotting; low levels raise clot risk.
- Lupus Anticoagulant — an antibody that prolongs the aPTT in the tube yet raises clot risk in the body.
Fibrinogen is reported as mg/dL in the US and g/L elsewhere; a unit converter helps line up your report with a reference range.
When doctors order it
A handful of situations recur:
- Before surgery or a procedure, to estimate bleeding risk, especially with a personal or family history of bleeding.
- To start and monitor blood thinners — warfarin is tracked with the INR, unfractionated heparin with the aPTT.
- To investigate bleeding or bruising that seems out of proportion — frequent nosebleeds, very heavy periods, easy bruising.
- To help rule out a clot — a D-dimer is used, in the right clinical context, when a deep-vein thrombosis or pulmonary embolism is suspected.
- To work up recurrent miscarriage or an unprovoked clot, where antithrombin III and the lupus anticoagulant form part of a wider thrombophilia screen.
How to prepare
Standard clotting tests need no fasting and can be drawn at any time. What matters most is your medication list: warfarin, heparin, direct oral anticoagulants, aspirin, and supplements such as fish oil, high-dose vitamin E and vitamin K all influence results — tell the lab so your numbers are read correctly. Direct oral anticoagulants deserve special mention: they can distort the aPTT and PT and cause a false-positive lupus anticoagulant, so testing is often timed around the last dose. The sample tube must be filled to its mark, because the blood-to-additive ratio affects the reading and an underfilled tube may need a redraw. Thrombophilia tests such as antithrombin III are usually postponed until you are off anticoagulants and away from an acute clot.
How to read the results together
The value is in the pattern, not any single number.
- A long aPTT with a normal PT points to the intrinsic arm — heparin, an inherited factor deficiency such as hemophilia, or a lupus anticoagulant. A follow-up mixing study separates a missing factor from an antibody that blocks clotting.
- Both PT and aPTT prolonged suggests a problem in the shared common pathway, liver disease, vitamin K deficiency, too much warfarin, or disseminated intravascular coagulation — in which fibrinogen falls and D-dimer climbs at the same time.
- A high D-dimer on its own is not a clot. It rises with infection, surgery, pregnancy, cancer and age; its power is the reverse — a normal D-dimer reliably rules a clot out in someone at low risk.
When to retest
Timing depends on why the test was done. On warfarin the INR is checked often at first, then roughly every two to four weeks once it is stable, as your clinic directs. On intravenous heparin the aPTT is repeated every few hours until it sits in range. A D-dimer is not a monitoring test — one result answers one question. Thrombophilia findings such as a low antithrombin III or a positive lupus anticoagulant are provisional until confirmed on a repeat sample about twelve weeks later, because a recent clot or illness can shift them temporarily. Always follow the interval your own doctor sets.
